Cancer Clinical Trials: Proactive Strategies
Springer-Verlag New York Inc.
978-0-387-33224-6 (ISBN)
Historical Perspective and Evolving Concerns for Human Research.- Cancer Trials and the Institutional Review Board (IRB).- NCI’s Cancer Therapy Evaluation Program: A Commitment to Treatment Trials.- The Role of the FDA in Cancer Clinical Trials.- The Role of Cooperative Groups in Cancer Clinical Trials.- The Advocate Role in Clinical Study Development and Partnering with Patient Advocates in Your Local Institution.- The National Breast Cancer Coalition: Setting the Standard for Advocate Collaboration in Clinical Trials.- The Role of the Principal Investigator in Cancer Clinical Trials.- The Audit Process and How to Ensure a Successful Audit.- The Privacy Rule (HIPAA) as it Relates to Clinical Research.- The Commission on Cancer, American College of Surgeons’ Response to HIPAA.- Ethical and Legal Issues in the Conduct of Cancer Clinical Trials.- The Role of the Office of Research Integrity in Cancer Clinical Trials.- Strategies for the Administration of a Clinical Trials Infrastructure: Lessons from a Comprehensive Cancer Center.- The Clinical Research Process: Building a System in Harmony with its Users.- Cancer Research and Clinical Trial in Action: An Important Exercise Before You Embark on Your Study.
Erscheint lt. Verlag | 14.5.2007 |
---|---|
Reihe/Serie | Cancer Treatment and Research ; 132 |
Zusatzinfo | XX, 320 p. |
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 156 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
ISBN-10 | 0-387-33224-3 / 0387332243 |
ISBN-13 | 978-0-387-33224-6 / 9780387332246 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich